Cardiometabolic disease staging predicts effectiveness of weight-loss therapy to prevent type 2 diabetes: Pooled results from phase III clinical trials assessing phentermine/topiramate extended release

Fangjian Guo, W. Timothy Garvey

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Cardiometabolic disease staging predicts effectiveness of weight-loss therapy to prevent type 2 diabetes: Pooled results from phase III clinical trials assessing phentermine/topiramate extended release'. Together they form a unique fingerprint.

Medicine & Life Sciences